首页> 外国专利> EXTRACT OF CHRYSANTHEMUM INDICUM LEAVES HAVING INHIBITORY EFFECTS ON PROTEIN TYROSINE PHOSPHATASE 1B AND A COMPOSITION COMPRISING THE SAME FOR PREVENTING OR TREATING METABOLIC DISEASES

EXTRACT OF CHRYSANTHEMUM INDICUM LEAVES HAVING INHIBITORY EFFECTS ON PROTEIN TYROSINE PHOSPHATASE 1B AND A COMPOSITION COMPRISING THE SAME FOR PREVENTING OR TREATING METABOLIC DISEASES

机译:菊苣叶提取物对蛋白质酪氨酸磷酸酶1B具有抑制作用,其组成与预防或治疗代谢性疾病相同

摘要

The present invention provides a chrysanthemum indicum leaf extract for inhibiting protein tyrosine phosphatase 1B (PTP1B) and a composition including the same for preventing or treating metabolic diseases. According to the present invention, the chrysanthemum indicum leaf extract has PTP1B inhibitor activities and the composition including the chrysanthemum indicum leaf extract has excellent effects in preventing adipopexia, reducing blood sugar, and preventing and treating diabetes so as to be useful as an agent for preventing or treating metabolic diseases. Moreover, the composition according to the present invention is appropriate for oral administration so as to have high bio-availability when being used as an agent for preventing and treating metabolic diseases through PTP1B inhibiting functions, and is made from a natural material so that side effects including toxicity can be reduced compared to PTP1B inhibitor compounds which are produced through synthesis.
机译:本发明提供了用于抑制蛋白质酪氨酸磷酸酶1B(PTP1B)的菊花叶提取物和包括其的用于预防或治疗代谢疾病的组合物。根据本发明,菊花叶提取物具有PTP1B抑制剂活性,并且包含菊花叶提取物的组合物在预防肥胖症,降低血糖以及预防和治疗糖尿病方面具有优异的效果,从而可用作预防剂。或治疗新陈代谢疾病。此外,根据本发明的组合物适于口服给药,从而在用作通过PTP1B抑制功能预防和治疗代谢疾病的药物时具有高生物利用度,并且由天然材料制成,具有副作用与通过合成产生的PTP1B抑制剂化合物相比,可以降低包括毒性在内的毒性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号